Annual Report to the Nation on the Status of Cancer
More information about the Annual Report to the Nation, including key findings and associated charts, graphs, and social media tools, is available on the SEER site.
Part 1 of the latest Annual Report to the Nation on the Status of Cancer was released on October 27, 2022. In addition to providing rates of new cases and deaths for the most common cancers in the United States, this year’s report also examines trends in pancreatic cancer and its subtypes in detail.
Among the findings of the report:
- Overall cancer death rates continued to fall among men, women, children, and adolescents and young adults in every major racial and ethnic group in the United States from 2015 to 2019.
- Overall cancer incidence rates remained stable for men and children but increased for women and adolescents and young adults from 2014 to 2018.
- From 2001 to 2018, incidence rates of pancreatic cancer increased by 1% per year among both men and women.
- From 2001 to 2019, death rates from pancreatic cancer increased by 0.2% per year for both sexes.
- From 2001 to 2018, incidence rates of two common subtypes of pancreatic cancer, neuroendocrine tumors and adenocarcinomas, increased in both men and women, while unspecified subtypes and other pancreatic tumors decreased.
Part 2 of the Annual Report to the Nation on the Status of Cancer was released September 27, 2023. This report examines the impact of the COVID-19 pandemic on new cases and deaths from certain cancers.
Among the findings of the report:
- New diagnoses of six major cancer types in the United States fell abruptly in early 2020, but by July 2020, diagnoses of all cancer types except prostate cancer had returned to pre-pandemic levels.
- Electronic pathology reports also declined steeply in early 2020 before returning to pre-pandemic levels.
- New cases of early-stage cancers fell more sharply than new cases of advanced cancers.
- Asian or Pacific Islander populations had greater declines in new cases of all cancer types except for pancreatic cancer, compared with white, Black, and American Indian or Alaska Native populations.
